StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.76+0.00 (+0.07%)

Close on Nov 17, 2026Market cap $34.21MP/E –Yield –

TELA Bio total assets

Total assets on the balance sheet at the end of each period.

TELA Bio's total assets was $59.74M at Jun 30, 2026. For fiscal 2025 it was $81.42M, down 6.0% from the year before. The highest annual figure on record is $86.57M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$81.42M-6.0%
FY2024Dec 31, 2024$86.57M+10.9%
FY2023Dec 31, 2023$78.05M+15.0%
FY2022Dec 31, 2022$67.86M+8.5%
FY2021Dec 31, 2021$62.54M-27.7%
FY2020Dec 31, 2020$86.46M+27.3%
FY2019Dec 31, 2019$67.92M+149.5%
FY2018Dec 31, 2018$27.23M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$59.74M-11.5%
Q1 FY2026Mar 31, 2026$69.89M-9.5%
Q4 FY2025Dec 31, 2025$81.42M-6.0%
Q3 FY2025Sep 30, 2025$61.59M+16.2%
Q2 FY2025Jun 30, 2025$67.54M+12.2%
Q1 FY2025Mar 31, 2025$77.25M+7.5%
Q4 FY2024Dec 31, 2024$86.57M+10.9%
Q3 FY2024Sep 30, 2024$53.02M-39.3%
Q2 FY2024Jun 30, 2024$60.20M-36.2%
Q1 FY2024Mar 31, 2024$71.84M+22.2%
Q4 FY2023Dec 31, 2023$78.05M+15.0%
Q3 FY2023Sep 30, 2023$87.32M+9.7%
Q2 FY2023Jun 30, 2023$94.39M+83.9%
Q1 FY2023Mar 31, 2023$58.79M+6.2%
Q4 FY2022Dec 31, 2022$67.86M+8.5%
Q3 FY2022Sep 30, 2022$79.56M+15.6%
Q2 FY2022Jun 30, 2022$51.33M-30.4%
Q1 FY2022Mar 31, 2022$55.36M-29.3%
Q4 FY2021Dec 31, 2021$62.54M-27.7%
Q3 FY2021Sep 30, 2021$68.81M-25.5%
Q2 FY2021Jun 30, 2021$73.80M-24.3%
Q1 FY2021Mar 31, 2021$78.32M+33.1%
Q4 FY2020Dec 31, 2020$86.46M+27.3%
Q3 FY2020Sep 30, 2020$92.35M+239.2%
Q2 FY2020Jun 30, 2020$97.55M–
Q1 FY2020Mar 31, 2020$58.84M–
Q4 FY2019Dec 31, 2019$67.92M–
Q4 FY2018Dec 31, 2018$27.23M–

More TELA Bio figures

See a number that looks wrong?